AIIMS Delhi to hold 2nd session of National CGR on COVID-19 issues tod

▴ AIIMS Delhi to hold 2nd session of National CGR on COVID-19 issues tod
AIIMS is conducting a series of webinars to help the physicians across the country

All India Institute of Medical Sciences (AIIMS), Delhi will hold the second session of National Clinical Grand Rounds (CGR) at 3 PM today. The interactive session, which will be led by AIIMS Director, Dr. Randeep Guleria, is aimed at facilitating insightful discussion on COVID related issues. Senior doctors of the premier health Institute will be discussing on the usage of antiviral and anti-IL6 drugs in moderately severe COVID cases.

Doctors from medical colleges and Senior Physicians from hospitals located across the country and abroad will be participating in the online session. In an effort to share its experience and initiate discussions on management of common issues related to COVID-19, AIIMS Delhi with NITI Aayog and Union Health Ministry launched the National Clinical Grand Rounds (CGR) on COVID-19.

These sessions include presentation of clinical cases by physicians directly involved in COVID management. Challenges faced in the management are also discussed by a panel of eminent experts from across the country and outside India.

All India Institute of Medical Sciences, Delhi held the first interactive session of National Clinical Grand Rounds led by AIIMS Director, Dr. Randeep Guleria on 22nd July.

The session was aimed at facilitating discussion on issues related to COVID-19. Doctors from medical colleges and Senior Physicians from hospitals located across the country and abroad participated in the online session.

Speaking on the occasion, Dr. Guleria said, the objective of National Clinical Grand Rounds is to bring down the mortality rate in COVID-19 patients to less than one percent. He said that COVID-19 is a national crisis and that there was a need for a common platform for clinical issues and case-based learning. The first CGR session focused on managing patients with Severe Acute Respiratory Infection, who are clinically suspected to have COVID-19 but test negative in the initial RT-PCR.

AIIMS has been extensively involved in managing patients, developing guidelines, policies and research in COVID-19. The Institute has managed over 4,000 patients of all levels of severity of the disease.

In an effort to share its experience and initiate discussions on management of common issues related to COVID-19, AIIMS Delhi in conjunction with NITI Aayog and Union Health Ministry has launched the National Clinical Grand Rounds (CGR) on COVID-19.

The sessions included the presentation of clinical cases by physicians directly involved in COVID management. Challenges faced inpatient management will be discussed by a panel of eminent experts from across the country and abroad. Physicians also asked questions related to patient management during the Question and Answer session.

Tags : #AIIMS #Delhi #CGR #NationalClinicalGrandRounds #FightingCorona #NITIAyog #AIIMSNews #CovidNewsUpdateJuly29

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

DCGI Acts Against Overcharging: New Regulations for Blood CentresMay 17, 2024
Cattle as Hosts for Human and Bird Flu Viruses: A Potential Public Health ConcernMay 17, 2024
The Ethics of Live Surgery Broadcasts: NMC Seeks Public OpinionMay 17, 2024
Successful Removal of 3.7 KG Large Abdominal Tumor from 14-Year-Old Somalian Girl at KIMS Cuddles HospitalMay 16, 2024
iLEAD Sets a Precedent by Launching a Graphic Anthology Authored by Multimedia, Animation and Graphics Students May 16, 2024
Ramaiah Memorial Hospital Launches Novel Intra-Operative Radiation Therapy (IORT); Achieves significant advancement in Cancer Treatment to Enhance Quality of LifeMay 16, 2024
IIITH Announces Product Management Summer SchoolMay 16, 2024
Çelebi India's Delhi Cargo Terminal Successfully Handles Airbus H125 Helicopter ShipmentMay 16, 2024
Plant-Based Diets and Prostate Cancer: New UCSF Study Shows Promising ResultsMay 16, 2024
National Medical Commission Approves 112 New Medical CollegesMay 16, 2024
Study Suggests That Chemotherapy Results in Physical Decline for Older Women with Breast CancerMay 16, 2024
Google DeepMind's AlphaFold 3: Revolutionizing Drug Discovery with AIMay 16, 2024
Hester Biosciences Ltd reports Consolidated Revenue growth of 18% at Rs. 79.3 crore, EBITDA up 37% to Rs. 16.4 crore and Net Profit up 12% to Rs. 6.40 crore in Q4FY24May 16, 2024
Akshay Tritiya Parna Mahotsav heldMay 16, 2024
IT Minister Sridhar Babu to grace the 10th National Facilities Managers Summit-2024, to be held in the cityMay 15, 2024
Alarming Study Reveals Cancer-Causing Chemicals in Car InteriorsMay 15, 2024
India's Thalassemia Challenge: The Importance of Early Screening and TreatmentMay 15, 2024
The Dangers of Ultra-Processed Foods: A 30-Year Study Raises AlarmsMay 15, 2024
Unique Genetic Risk Factors for Breast Cancer Found in African Ancestry StudyMay 15, 2024
AsiaMedic partners with Sunway to establish new diagnostic imaging centreMay 14, 2024